Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

NCT: NCT05726526 · RECRUITING

NCT IDNCT05726526
StatusRECRUITING
Start Date2022-06-30
Completion2028-03-30
SponsorUniversity of Manitoba (OTHER)
First posted
Last updated

Brief Summary

The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care will lead to a reduction in composite emergency department (ED) visits and/or hospitalizations/or increase the perceived safety of virtual care among patients and providers.

Frequently Asked Questions

What is CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients?

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients is a clinical trial registered under NCT05726526. Current status: RECRUITING.

What is the status of NCT05726526?

The current status of NCT05726526 (CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients) is: RECRUITING.

When did CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients start?

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients started on 2022-06-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑